RENT.COM.AU LIMITED — Capital/Financing Update 2004

Jun 20, 2004

ASX ANNOUNCEMENT Securities to be Released from Escrow

Melbourne, Australia. 18 June 2004.

In accordance with ASX Listing Rule 3.10A the Company advises that the following unlisted securities will be released from escrow on 28 June 2004:

2,000,000 unlisted options exercisable at $0.20 on or before 30 June 2006. $\bullet$

For further information please contact Mr. Phillip Hains, Company Secretary.

Jeremy Cooper Director

About Select Vaccines Limited

Select Vaccines listed on the ASX on 3 July 2003. It is in partnership with Melbourne's Burnet Institute to commercialise research outcomes in the areas of diagnosis, vaccination and therapy for infectious diseases caused by viruses.

The Burnet Institute, established in 1986, is Australia's leading research organisation in the field of infectious diseases caused by viruses and other agents.

Select has formed two project companies, Hepgenics Pty Ltd and Picoral Pty Ltd, to underfake different areas of research and development. Hepgenics is commercialising highly promising R&D projects in hepatitis diagnostics and vaccines developed by researchers at the Burnet Institute. Picoral's research interests cover the development of therapeutic products with actions against the picornavirus family, responsible for a range of illnesses that includes the common cold, meningitis and encephalitis.

ENDS